Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LYPLA1 inhibitors(lysophospholipase 1 inhibitors), LYPLA2 inhibitors(lysophospholipase 2 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H32ClN5O6 |
InChIKeyKQQSWNNGVFWIEL-UHFFFAOYSA-N |
CAS Registry1831135-21-7 |